Cyril Amarchand Mangaldas (CAM) acted as legal counsel to KKR on its acquisition of a majority stake and sole control of ...

KKR & Co Inc. is set to acquire a majority stake in India’s Healthcare Global Enterprises Ltd. from CVC Capital Partners at a ...

The group will purchase up to 54% of HCG’s equity at $5.14 (INR 445) per share. Global investment firm KKR has signed ...

US investment firm KKR has entered an agreement to acquire an additional 5% stake in Italian energy major Eni’s biofuel ...

KKR said it has agreed to acquire a controlling stake in cancer treatment chain HealthCare Global Enterprises Ltd (HCG) from ...

KKR (KKR) announced to acquire a controlling stake in Indian hospital operator HealthCare Global Enterprises for $400 million ...

After the KKR acquisition of Perpetual’s wealth management and corporate trust business collapsed and the company’s ...

US private equity firm KKR & Co. will acquire a majority stake in HealthCare Global Enterprises Ltd. for around Rs 3,350 ...

KKR, a leading global investment firm, and Healthcare Global Enterprises (HCG) have signed a definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR ...

Global investment firm KKR has agreed to acquire a controlling stake in Bengaluru-based Healthcare Global Enterprises (HCG) ...

As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.